RAPT Therapeutics $143.7 million follow-on offering
We advised the joint book-running managers on the SEC-registered equity offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Paymentus $241.5 million IPO
The shares are listed on the New York Stock Exchange
Valens Semiconductor’s business combination with PTK Acquisition Corp.
We are advising Valens on its business combination with a SPAC
Fluor $600 million convertible preferred stock offering
The company issued Series A cumulative perpetual convertible preferred stock
Aveanna $458.8 million IPO
We advised the underwriters on the IPO and Nasdaq listing
NeuroPace $102 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
Alkami Technology $207 million IPO
We advised the underwriters on the IPO and Nasdaq listing
VIZIO Holding $257.2 million IPO
We advised the underwriters on the IPO and NYSE listing
Twitter $1.25 billion convertible senior notes offering
The Rule 144A offering involved 0% convertible notes due 2026
AVITA Medical $69.1 million follow-on offering
We advised the underwriters on the equity offering